VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
L
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
LLoews Corporation
$116.95$24.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksLQuarterly Financials

Loews Corporation (L) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Loews Corporation (L) quarterly income statement — complete revenue, gross profit & net income history

L Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue4.55B4.66B4.6B4.47B4.44B4.47B4.4B4.19B4.18B4.19B3.9B3.83B3.76B3.79B3.49B3.38B3.38B3.57B3.28B3.3B
Revenue Growth %2.64%4.27%4.64%6.7%6.25%6.63%12.88%9.39%11.21%10.49%11.57%13.37%11.06%6.24%6.43%2.49%-5.4%-1.03%-3.3%-4.76%
Medical Costs & Claims2.17B2.63B2.52B2.55B2.5B2.49B2.48B2.32B2.25B02.25B2.18B2.03B2.07B2.26B1.98B1.82B2.02B2B1.9B
Medical Cost Ratio %47.75%56.32%54.64%57.09%56.29%55.75%56.29%55.26%53.89%0%57.79%56.93%54.1%54.61%64.79%58.41%53.87%56.68%60.94%57.68%
Gross Profit2.38B2.04B2.09B1.92B1.94B1.98B1.92B1.88B1.93B4.19B1.65B1.65B1.72B1.72B1.23B1.41B1.56B1.55B1.28B1.4B
Gross Margin %52.25%43.68%45.36%42.91%43.71%44.25%43.71%44.74%46.11%100%42.21%43.07%45.9%45.39%35.21%41.59%46.13%43.32%39.06%42.32%
Gross Profit Growth %22.68%2.93%8.58%2.35%0.73%-52.81%16.9%13.63%11.72%143.44%33.74%17.43%10.51%11.31%-4.06%0.72%-8.77%-11.95%-9.59%-5.68%
Operating Expenses1.84B1.5B1.4B1.38B1.43B1.79B1.37B1.37B1.3B3.58B1.29B1.14B1.21B1.25B1.25B1.17B1.12B1.09B978M384M
OpEx / Revenue %40.42%32.07%30.39%30.87%32.13%40.04%31.21%32.65%31.05%85.38%33.08%29.82%32.08%32.84%35.93%34.63%33.15%30.47%29.8%11.64%
Depreciation & Amortization00000000000000000000
Combined Ratio %88.17%88.39%85.03%87.95%88.42%95.79%87.5%87.91%84.94%85.38%90.86%86.75%86.18%87.45%100.72%93.05%87.02%87.15%90.74%69.32%
Operating Income539M541M689M539M514M188M550M507M629M613M356M508M519M476M-25M235M439M459M304M1.01B
Operating Margin %11.83%11.61%14.97%12.05%11.58%4.21%12.5%12.09%15.06%14.62%9.14%13.25%13.82%12.55%-0.72%6.95%12.98%12.85%9.26%30.68%
Operating Income Growth %4.86%187.77%25.27%6.31%-18.28%-69.33%54.49%-0.2%21.19%28.78%1524%116.17%18.22%3.7%-108.22%-76.78%7.86%-16.24%66.12%194.23%
EBITDA539M654M801M646M619M298M550M621M732M678M450M599M614M570M67M331M535M559M403M1.11B
EBITDA Margin %11.83%14.03%17.4%14.44%13.95%6.67%12.5%14.81%17.52%16.17%11.55%15.63%16.35%15.02%1.92%9.79%15.82%15.65%12.28%33.71%
Interest Expense113M113M112M107M105M110M114M114M103M96M94M91M95M94M92M96M96M100M99M100M
Non-Operating Income0-113M-112M-107M-105M-110M0-114M-103M-65M-94M-91M-95M-94M-92M-96M-96M-100M-99M-100M
Pretax Income463M541M689M539M514M188M550M507M629M613M356M508M519M476M-25M235M439M459M304M1.01B
Pretax Margin %10.16%11.61%14.97%12.05%11.58%4.21%12.5%12.09%15.06%14.62%9.14%13.25%13.82%12.55%-0.72%6.95%12.98%12.85%9.26%30.68%
Income Tax-109M113M153M123M122M-1M125M112M144M136M80M120M115M88M2M48M87M88M58M219M
Effective Tax Rate %-23.54%20.89%22.21%22.82%23.74%-0.53%22.73%22.09%22.89%22.19%22.47%23.62%22.16%18.49%-8%20.43%19.82%19.17%19.08%21.64%
Net Income572M402M504M391M370M187M401M369M457M446M253M360M375M364M-22M167M322M343M220M754M
Net Margin %12.56%8.62%10.95%8.74%8.34%4.18%9.12%8.8%10.94%10.64%6.49%9.39%9.98%9.59%-0.63%4.94%9.52%9.61%6.7%22.86%
Net Income Growth %54.59%114.97%25.69%5.96%-19.04%-58.07%58.5%2.5%21.87%22.53%1250%115.57%16.46%6.12%-110%-77.85%23.37%-13.6%58.27%190.3%
EPS (Diluted)1.631.922.431.871.740.861.821.670.151.981.121.581.611.520.540.681.291.370.852.86
EPS Growth %-6.32%123.26%33.52%11.98%1060%-56.57%62.5%5.7%-90.68%30.26%107.41%132.35%24.81%10.95%-36.47%-76.22%32.99%-0.72%70%196.3%
EPS (Basic)1.631.942.431.871.740.861.831.672.051.991.121.581.611.530.540.681.301.370.862.87
Diluted Shares Outstanding206.27M209.1M209.36M209.36M212.64M217.83M219.94M221.6M222.93M224.88M225.99M227.97M233.62M238.08M240.76M245.94M248.48M252.52M257.3M263.34M